ESC 365 - Modeling of an SCN5A founder mutation in iPSC-derived cardiomyocytes

CBS PREMIUM ACCESS

Modeling of an SCN5A founder mutation in iPSC-derived cardiomyocytes

Session: Poster Session 1

Topic: Arrhythmias

Speaker: Miss E. Simons (Antwerp, BE)

Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

Add to my library

About the speaker

Miss Eline Simons

University of Antwerp, Antwerp (Belgium)

0 follower

73 more presentations in this session

Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients

Speaker: Miss E. Bevilacqua (Seville, ES)

Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring

Speaker: Doctor K. Viligorska (Chernivtsi, UA)

Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study

Speaker: Mr C. Rios Navarro (Valencia, ES)

Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion

Speaker: Associate Professor L. Tacu (Chisinau, MD)

Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets

Speaker: Doctor B. Agg (Budapest, HU)

Access the full session

Poster Session 1

Speakers: Miss E. Simons, Miss E. Bevilacqua, Doctor K. Viligorska, Mr C. Rios Navarro, Associate Professor L. Tacu...

About the event

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources